{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:19:18Z","timestamp":1778721558048,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2020FYYX248"],"award-info":[{"award-number":["2020FYYX248"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701950"],"award-info":[{"award-number":["81701950"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172135"],"award-info":[{"award-number":["82172135"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["KY2019Y002"],"award-info":[{"award-number":["KY2019Y002"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.hbpd.2022.03.012","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T21:47:42Z","timestamp":1647899262000},"page":"358-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Laparoscopic liver resection for hepatocellular carcinoma complicated with significant portal hypertension: A propensity score-matched survival analysis"],"prefix":"10.1016","volume":"22","author":[{"given":"Zhang-You","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2022.03.012_bib0001","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study","volume":"5","author":"Global Burden of Disease Cancer Collaboration","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0002","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","article-title":"The global burden of cancer 2013","volume":"1","author":"Fitzmaurice","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0003","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0004","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1053\/j.gastro.2008.02.091","article-title":"Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma","volume":"134","author":"Ishizawa","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0005","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00423-020-02056-x","article-title":"Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma","volume":"406","author":"Lopez-Lopez","year":"2021","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0006","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3181b977a5","article-title":"Is portal hypertension a contraindication to hepatic resection?","volume":"250","author":"Cucchetti","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0007","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00464-017-5930-1","article-title":"Benefits of laparoscopic liver resection in patients with hepatocellular carcinoma and portal hypertension: a case-matched study","volume":"32","author":"Molina","year":"2018","journal-title":"Surg Endosc"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0008","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1007\/s00268-020-05687-9","article-title":"Laparoscopic liver resection for hepatocellular carcinoma in Child-Pugh A patients with and without portal hypertension: a multicentre study","volume":"44","author":"Casellas-Robert","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0009","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijsu.2017.08.586","article-title":"The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery","volume":"46","author":"Agha","year":"2017","journal-title":"Int J Surg"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0010","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMra1610570","article-title":"Use of liver imaging and biopsy in clinical practice","volume":"377","author":"Tapper","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0011","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hep.27431","article-title":"Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis","volume":"61","author":"Berzigotti","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0012","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"53","author":"de Franchis","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0013","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0014","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/01.sla.0000189131.90876.9e","article-title":"The \"50-50 criteria\" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy","volume":"242","author":"Balzan","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0015","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3982\/ECTA11293","article-title":"Matching on the estimated propensity score","volume":"84","author":"Abadie","year":"2016","journal-title":"Econometrica"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0016","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0017","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/hep.27702","article-title":"Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. More doubts than clarity","volume":"62","author":"Cucchetti","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0018","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jhbp.124","article-title":"Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"21","author":"Choi","year":"2014","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0019","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jhep.2017.10.024","article-title":"Should living donor liver transplantation be an option when deceased donation is not?","volume":"68","author":"Lieber","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0020","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.3748\/wjg.v20.i17.4892","article-title":"Laparoscopic liver resections for hepatocellular carcinoma: current role and limitations","volume":"20","author":"Gaillard","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0021","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/hep.28339","article-title":"Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection","volume":"63","author":"Ferrer-F\u00e0brega","year":"2016","journal-title":"Hepatology"},{"issue":"511","key":"10.1016\/j.hbpd.2022.03.012_bib0022","first-page":"e1","article-title":"Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH","volume":"146","author":"Forner","year":"2016","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0023","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2012.11.009","article-title":"Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey","volume":"58","author":"Hasegawa","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0024","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s11605-018-3981-9","article-title":"Benefits of splenectomy and curative treatments for patients with hepatocellular carcinoma and portal hypertension: a retrospective study","volume":"23","author":"Pei","year":"2019","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0025","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1007\/s00464-020-07763-6","article-title":"Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study","volume":"35","author":"Zheng","year":"2021","journal-title":"Surg Endosc"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0026","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1148\/radiol.13130940","article-title":"Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis","volume":"270","author":"Lee","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0027","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ajg.2011.425","article-title":"Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors","volume":"107","author":"Shiina","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0028","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/lt.23904","article-title":"Alpha-fetoprotein level >1000 ng\/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria","volume":"20","author":"Hameed","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0029","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/TP.0000000000002094","article-title":"Alpha-fetoprotein slope >7.5 ng\/mL per month predicts microvascular invasion and tumor recurrence after liver transplantation for hepatocellular carcinoma","volume":"102","author":"Giard","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0030","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2016.10.038","article-title":"Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC","volume":"66","author":"Notarpaolo","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0031","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00432-018-2756-8","article-title":"Analysis of prognostic factors of more\/equal to 10 years of survival for liver cancer patients after liver transplantation","volume":"144","author":"Li","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0032","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12072-017-9807-0","article-title":"Impact of etiological treatment on prognosis","volume":"12","author":"Su","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0033","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jhep.2018.12.027","article-title":"Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3\u00a0cm in potentially transplantable patients","volume":"70","author":"Doyle","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.03.012_bib0034","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/cancers12020313","article-title":"Multimodal percutaneous thermal ablation of small hepatocellular carcinoma: predictive factors of recurrence and survival in Western patients","volume":"12","author":"Hermida","year":"2020","journal-title":"Cancers (Basel)"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387222000509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387222000509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:44:25Z","timestamp":1761493465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387222000509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1499387222000509"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2022.03.012","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laparoscopic liver resection for hepatocellular carcinoma complicated with significant portal hypertension: A propensity score-matched survival analysis","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2022.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}